{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:32:08Z","timestamp":1782516728799,"version":"3.54.5"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ctim.2022.102808","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T01:50:07Z","timestamp":1643421007000},"page":"102808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["The effects of add-on therapy of Phyllanthus Emblica (Amla) on laboratory confirmed COVID-19 Cases: A randomized, double-blind, controlled trial"],"prefix":"10.1016","volume":"65","author":[{"given":"Mehran","family":"Varnasseri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Siahpoosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khojasteh","family":"Hoseinynejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fetemeh","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Karamian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Jafar Yad","family":"Yad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahman","family":"Cheraghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azar Dokht","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctim.2022.102808_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.008798","article-title":"Lopinavir-ritonavir treatment for COVID-19 Infection in intensive care unit: risk of bradycardia","volume":"13","author":"Beyls","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ctim.2022.102808_bib2","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa2015301","article-title":"Remdesivir for 5 or 10 days in patients with severe Covid-19","volume":"383","author":"Goldman","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ctim.2022.102808_bib3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1142\/S0192415X2050038X","article-title":"Becoming a faithful defender: traditional Chinese medicine against coronavirus disease 2019 (COVID-19)","volume":"48","author":"Zhang","year":"2020","journal-title":"Am J Chin Med"},{"issue":"1","key":"10.1016\/j.ctim.2022.102808_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1515\/JBCPP.2010.21.1.93","article-title":"Therapeutic potential of Phyllanthus emblica (amla): the ayurvedic wonder","volume":"21","author":"Krishnaveni","year":"2010","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"10.1016\/j.ctim.2022.102808_bib5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.phrs.2016.06.013","article-title":"Emblica officinalis (Amla): a review for its phytochemistry, ethnomedicinal uses and medicinal potentials with respect to molecular mechanisms","volume":"111","author":"Variya","year":"2016","journal-title":"Pharmacol Res"},{"issue":"7","key":"10.1016\/j.ctim.2022.102808_bib6","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/ptr.3368","article-title":"In vitro anti-herpes simplex virus activity of 1,2,4,6-tetra-O-galloyl-\u03b2-D-glucose from Phyllanthus emblica L. (Euphorbiaceae)","volume":"25","author":"Xiang","year":"2011","journal-title":"Phytother Res"},{"issue":"3","key":"10.1016\/j.ctim.2022.102808_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4103\/JISPPD.JISPPD_85_18","article-title":"In vitro evaluation of cytotoxicity of Emblica officinalis (amla) on cultured human primary dental pulp fibroblasts","volume":"37","author":"Bulbule","year":"2019","journal-title":"J Indian Soc Pedod Prev Dent"},{"issue":"7","key":"10.1016\/j.ctim.2022.102808_bib8","doi-asserted-by":"crossref","first-page":"FSO712","DOI":"10.2144\/fsoa-2020-0199","article-title":"Validation of red cell distribution width as a COVID-19 severity screening tool","volume":"7","author":"Pouladzadeh","year":"2021","journal-title":"Future Sci OA"},{"key":"10.1016\/j.ctim.2022.102808_bib9","series-title":"Clinical Management of COVID-19: Interim Guidance, 2020","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.ctim.2022.102808_bib10","first-page":"313","article-title":"Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants [published online ahead of print, 2020 Mar 26]","volume":"10","author":"Ul Qamar","year":"2020","journal-title":"J Pharm Anal"},{"issue":"5626","key":"10.1016\/j.ctim.2022.102808_bib11","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science."},{"issue":"Pt 5","key":"10.1016\/j.ctim.2022.102808_bib12","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1107\/S1399004715003521","article-title":"Structures of the Middle East respiratory syndrome coronavirus 3C-like protease reveal insights into substrate specificity","volume":"71","author":"Needle","year":"2015","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"7","key":"10.1016\/j.ctim.2022.102808_bib13","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/ptr.3368","article-title":"In vitro anti-herpes simplex virus activity of 1, 2, 4, 6-tetra-O-galloyl-\u03b2-D-glucose from Phyllanthus emblica L. (Euphorbiaceae)","volume":"25","author":"Xiang","year":"2011","journal-title":"Phytother Res"},{"issue":"1","key":"10.1016\/j.ctim.2022.102808_bib14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12917-020-02320-8","article-title":"In vitro screening antiviral activity of Thai medicinal plants against porcine reproductive and respiratory syndrome virus","volume":"16","author":"Arjin","year":"2020","journal-title":"BMC Vet Res"},{"issue":"6-7","key":"10.1016\/j.ctim.2022.102808_bib15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1078\/094471103322331872","article-title":"Antitussive activity of the fruit extract of Emblica officinalis Gaertn. (Euphorbiaceae)","volume":"10","author":"Nos\u00e1l'ov\u00e1","year":"2003","journal-title":"Phytomedicine."},{"issue":"1","key":"10.1016\/j.ctim.2022.102808_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jep.2004.06.020","article-title":"Evaluation of anti-pyretic and analgesic activity of Emblica officinalis Gaertn","volume":"95","author":"Perianayagam","year":"2004","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.ctim.2022.102808_bib17","first-page":"365","article-title":"Evaluation of analgesic activity of Emblica officinalis in albino rats. Int J Basic","volume":"3","author":"Goel","year":"2014","journal-title":"Clin Pharmacol"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229922000103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229922000103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:17:50Z","timestamp":1760807870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229922000103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":17,"alternative-id":["S0965229922000103"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2022.102808","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of add-on therapy of Phyllanthus Emblica (Amla) on laboratory confirmed COVID-19 Cases: A randomized, double-blind, controlled trial","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2022.102808","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102808"}}